// App-Quantinova.ai

4012 : Improving radiotherapy abscopal effects with anti-PD1 and anti-CD137-based immunotherapy

Researchers

Presenter

  • Maria E. Rodriguez-Ruiz

Principal Investigators

  • Inmaculada Rodriguez

  • Saray Garasa

  • Benigno Barbes

  • Jose Luis Solorzano

  • Jose Luis Perez Gracia

  • Sara Labiano

  • Arantza Azpilikueta

  • Elixabet Bolanos

  • Alfonso R. Sanchez-Paulete

  • M. Angela Aznar

  • Ana Rouzaut

  • Maria Jure-Kunkel

  • Inaki Etxeberria

  • Carlos Alfaro

  • Carmen Onate

  • Mariano Ponz

  • Ignacio Melero

Medical Centers

  • Clinica universidad de Navarra and centro de investigacion medica aplicada, Pamplona, Navarra, Spain

  • Bristol-Myers Squibb, Lawrenceville, NJ

Locations

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Breast cancer

  • Solid malignancies

  • Melanoma

Biomarkers

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Interferon-gamma

  • tumor-infiltrating lymphocytes

  • Regulatory T cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved